Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Other Disease Areas
Filter     Order     Display # 
Date Item Title
09 May 2007 AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
09 May 2007 ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine
08 May 2007 Adverse event with oral EPO FG-2216 in anemia treatment
08 May 2007 Nymox Announces New Positive Results from 3 1/2 Year Study of NX-1207 for Benign Prostatic Hyperplasia
08 May 2007 Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results For AT-1001 For The Treatment Of Celiac Disease
08 May 2007 CollaGenex Pharmaceuticals Discontinues 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne
05 May 2007 ISTA Provides Regulatory Update on T-Pred NDA Filing
02 May 2007 Sirion Therapeutics Initiates Two Phase III Clinical Trials
02 May 2007 University College London, Moorfields Eye Hospital and Targeted Genetics Initiate Phase I/II Clinical Trial of Gene Therapy for Childhood Blindness
01 May 2007 Northstar Neuroscience Announces Initial Feasibility Data on the Use of its Renova(TM) Cortical Stimulation System to Treat Tinnitus
01 May 2007 RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery
01 May 2007 Interim report about clinical trial of BF-200 ALA in actinic keratosis
28 Apr 2007 Cipher Pharmaceuticals Receives Approvable Letter From Fda For CIP-ISOTRETINOIN
27 Apr 2007 Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome
26 Apr 2007 Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
26 Apr 2007 Basilea Reports Positive Re-treatment Results from a Second Phase III Trial of Alitretinoin for Patients with Severe Chronic Hand Eczema
26 Apr 2007 Ceragenix Commences Second in Series of Clinical Trials
25 Apr 2007 TopoTarget announces next Phase II clinical placebo controlled trial with Avugane(TM) in acne vulgaris
25 Apr 2007 Protox Doses First Patient In Benign Prostatic Hyperplasia Trial Using PRX302
24 Apr 2007 Alimera Sciences' Medidur(TM) Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment
18 Apr 2007 Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
18 Apr 2007 Salix Pharmaceuticals Licenses DIACOL(TM) To Dr. Falk Pharma in Europe
17 Apr 2007 Genzyme Announces Successful Completion of Study Investigating Sevelamer Carbonate in Patients with Chronic Kidney Disease
17 Apr 2007 Bio3 Research and Daxley Group announce a Phase III trial will start in Mexico in May 2007 to evaluate the supportive treatment of Biocysan(TM), oral cysteine, in hemodialysed patients (End Stage Renal Disease)
13 Apr 2007 Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
12 Apr 2007 Senetek Initiates Clinical Trials of Pyratine 6 for Acne Rosacea Comparison of Pyratine 6 and Kinetin Clinicals Shows Dramatic Advancements
12 Apr 2007 Pharmaxis Begins Phase III Cystic Fibrosis Trial
12 Apr 2007 Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
11 Apr 2007 Novalar Submits New Drug Application for Anesthetic Reversal Agent NV-101
11 Apr 2007 CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy
05 Apr 2007 Merrimack Pharmaceuticals Initiates Enrollment in a Phase 2 Pilot Study of
05 Apr 2007 Eurand Announces Positive Phase III Clinical Study Results
05 Apr 2007 Meditrina Pharmaceuticals, Inc. Initiates phase II Trial and raises $4.4M in initial funding.
05 Apr 2007 Novagali Pharma Announces Positive Vekacia(R) Clinical Results from Pivotal Phase III Trial in Vernal Keratoconjunctivitis
04 Apr 2007 Repros' Proellex Shows Statistically Significant Improvement in Primary Endpoint in Phase 2 Trial in the Treatment of Uterine Fibroids
03 Apr 2007 Senetek PLC Grants Paid Up License to Valeant Pharmaceuticals
03 Apr 2007 Theravance Announces Positive Results of Clinical Program in Beyond Advair Collaboration
31 Mar 2007 RegeneRx Files IND to Begin Phase 2 Ophthalmic Clinical Trial
31 Mar 2007 Novartis suspends US marketing and sales of Zelnorm(R) in response to request from FDA
31 Mar 2007 Progenics and Wyeth Announce Submission of New Drug Application for the Subcutaneous Formulation of Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients Receiving Palliative Care
30 Mar 2007 NicOx Announces that Pfizer has Disclosed Further Details of Glaucoma Trial for PF-03187207
29 Mar 2007 Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil, Its New Long Acting Drug For Erectile Dysfunction
29 Mar 2007 Protox Initiates Phase I Study of PRX302 for Benign Prostatic Hyperplasia
29 Mar 2007 Anesiva Commences Phase 3 Clinical Study of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
29 Mar 2007 Clinical Development Initiated on Lead Compound in NicOx Glaucoma Collaboration with Pfizer
28 Mar 2007 Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
27 Mar 2007 HRA Pharma commences UK-based Phase III trial of Ella(R), a second-generation emergency contraceptive
23 Mar 2007 Ęterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
21 Mar 2007 MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R) Injection in Patients Undergoing Bronchoscopy
21 Mar 2007 Potentia Pharmaceuticals Announces Initiation of Phase I Clinical Trials to Evaluate its Lead Compound for Age-Related Macular Degeneration
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>
Results 601 - 650 of 1045

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Janus Kinase (JAK) Inhibitors

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics